Podcasts about patient access

Welcome to episode 29 of the NAHAM Connections Podcast, highlighting the latest trends and insights shaping the world of Patient Access. In this episode, host Susan Milligan, CHAM, CRCR, is joined by Sean Buzzard, a certified QPR expert and behavioral health response specialist with Ensemble Health Partners, for a timely discussion on managing workplace violence in healthcare settings. Sean shares how de-escalation strategies — grounded in empathy and the QPR (Question, Persuade, Refer) method — can help Patient Access professionals stay safe, respond effectively and connect patients with the right support. They also explore real-world scenarios, subtle cues to watch for and the importance of teamwork, training and emotional awareness. Tune in for takeaways that can help create a safer, more compassionate environment for both staff and patients. || LINKS *Episode* https://www.naham.org/page/ConnectionsCultivatingCalmNovantHealthsJourneytoEmployeeWell-beingandPositivity https://www.naham.org/page/ConnectionsTamingToughEncountersHandlingHigh-ConflictPersonalities https://www.naham.org/page/ConnectionsNavigatingaToxicWorkEnvironmentinaPatientAccessRole https://www.naham.org/page/ConnectionsPodcastEpisode22 https://www.naham.org/page/ConnectionsPodcastEpisode25 *Social Media* https://www.naham.org/page/NAHAMConnections | https://www.facebook.com/NAHAMDC/ | https://x.com/MyNAHAM | https://www.instagram.com/nahamdc/ | https://www.linkedin.com/company/national-association-of-healthcare-access-management-naham-/ *NAHAM Website* https://www.naham.org/ | https://www.naham.org/page/NAHAMConnections

Many hospitals lack real-time visibility into front-end revenue cycle metrics like prior auth status and registration accuracy. This episode explores how closing that visibility gap can reduce denials, improve staff performance, and drive better financial outcomes.Brought to you by www.infinx.com

Aniq Rahman, Founder and CEO of Fabric, a technology company that uses an AI-powered platform to support health systems, health plans, and employers, to streamline patient care, scheduling appointments, and receiving virtual care. The system can triage patients, route them to appropriate care, and simplify the provider workflows to improve operational efficiency, drive better patient outcomes, and reduce provider burnout. Fabric is taking an integrated approach to healthcare technology rather than offering individual point solutions in order to create a seamless experience for patients and providers. Aniq explains, "We started Fabric about four years ago now in 2021 in the midst of the pandemic. And we're a technology company fundamentally. So, Fabric builds technology. We work primarily with health systems, but also with health plans and employers, to really help bring together the care journey of a patient. So that's everything from helping a patient find care, triage their symptoms, get virtual care, and also help with things like scheduling appointments and follow-ups. So we've built really an end-to-end platform today that has AI at its core and is able to sort of route patients more appropriately and then also help improve the workflows of providers and create efficiency on the clinical side as well." "Yes, so one of the things that has been sort of core to the Fabric vision is figuring out ways to actually improve patient experience, provider experience, and operational throughput without it compromising any of those three buckets. And so one of the things that we've been fortunate to have is a virtual care platform that we actually acquired. We bought a company called Zipnosis back in 2023, and Zipnosis had built a pretty robust set of clinical protocols to help streamline the virtual urgent care visits effectively. So, say a patient's coming in with something like a pink eye or a urinary tract infection, or even just a cold or flu, we have protocols that allow patients to go through and answer a series of questions in an adaptive interview. And based on the patient responses, we can figure out if that patient needs to be seen in person or may need to get referred out to the emergency department."  #FabricHealth #MedAI #AI #DigitalAssistant #DigitalHealth #TriageEvaluation fabrichealth.com Download the transcript here

Aniq Rahman, Founder and CEO of Fabric, a technology company that uses an AI-powered platform to support health systems, health plans, and employers, to streamline patient care, scheduling appointments, and receiving virtual care. The system can triage patients, route them to appropriate care, and simplify the provider workflows to improve operational efficiency, drive better patient outcomes, and reduce provider burnout. Fabric is taking an integrated approach to healthcare technology rather than offering individual point solutions in order to create a seamless experience for patients and providers. Aniq explains, "We started Fabric about four years ago now in 2021 in the midst of the pandemic. And we're a technology company fundamentally. So, Fabric builds technology. We work primarily with health systems, but also with health plans and employers, to really help bring together the care journey of a patient. So that's everything from helping a patient find care, triage their symptoms, get virtual care, and also help with things like scheduling appointments and follow-ups. So we've built really an end-to-end platform today that has AI at its core and is able to sort of route patients more appropriately and then also help improve the workflows of providers and create efficiency on the clinical side as well." "Yes, so one of the things that has been sort of core to the Fabric vision is figuring out ways to actually improve patient experience, provider experience, and operational throughput without it compromising any of those three buckets. And so one of the things that we've been fortunate to have is a virtual care platform that we actually acquired. We bought a company called Zipnosis back in 2023, and Zipnosis had built a pretty robust set of clinical protocols to help streamline the virtual urgent care visits effectively. So, say a patient's coming in with something like a pink eye or a urinary tract infection, or even just a cold or flu, we have protocols that allow patients to go through and answer a series of questions in an adaptive interview. And based on the patient responses, we can figure out if that patient needs to be seen in person or may need to get referred out to the emergency department."  #FabricHealth #MedAI #AI #DigitalAssistant #DigitalHealth #TriageEvaluation fabrichealth.com  Listen to the podcast here

There are many experimental drugs being tested for various conditions, but many of them never get to real patients due to obstacles like low rates of clinical trial participation. Dr. Casey Chapman explains a growing research method that brings the trials directly to patients and gives them the opportunity to access a wider range of medications. Learn More: https://radiohealthjournal.org/increasing-patient-access-to-experimental-drugs Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Dr. Elisabeth Potter shares her journey as a leading reconstructive microsurgeon, the challenges of staying in-network with insurers, and her mission to expand access to high-quality breast reconstruction. She also sounds the alarm on how current insurance structures threaten independent medical practices and patient care.

AI agents aren't magic, but they're not vaporware either. This fast episode breaks down how they're being used today to reduce manual touches and improve speed.

At the 2025 Patient Access Collaborative Symposium, Stephanie Schmidt, MS, Senior Director of Ambulatory Operations, and Adam Stone, MS, Director of Clinical Data & Analytics of Oregon Health & Science University led a high-impact workshop on building a culture of data fluency and accountability in access operations. As leaders in both operations and analytics, Stephanie and Adam shared real-world examples of how their teams are aligning key performance indicators (KPIs) with meaningful metrics, using dashboards to bring data to life, and building the infrastructure for consistent governance across departments. Their focus: turning insights into action—and making data not just visible, but transformative.In this episode, they reflect on the collective wisdom shared by access leaders nationwide—from the most common metrics (like fill rate and new patient lag) to the shared barriers (like attribution and cultural resistance). They also unpack the often-overlooked ROI of access initiatives, discuss how to improve organizational fluency, and share their aspirations for the future of access analytics. Whether you're launching a dashboard or leading enterprise-wide transformation, this conversation offers powerful takeaways to guide your next step.

Congressman Craig Murphy, a practicing physician and member of Congress from North Carolina, shares insights on current legislation and the state of healthcare in America. Congressman Murphy discusses the FBI's investigation into political conspiracies, the challenges facing Medicaid, and the importance of reforming the healthcare system to better serve those in need. He also addresses misinformation surrounding healthcare policies and the need for transparency and accountability in government. Next, former Deputy National Security Adviser Victoria Coates joins to discuss the recent NATO meeting with President Trump, the implications of sending Patriot missiles to Ukraine, and the potential for tougher sanctions on Russia. Victoria shares insights on how these developments could reshape international relations, particularly concerning China and the Middle East. Finally, former Trump lawyer and legal expert John Eastman delves into the decision by the FBI to open a grand conspiracy investigation focusing on alleged misconduct by Democrats over the past decade.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Benj Kamm and Jonathan Aguiar introduce a major new feature in the Infinx Patient Access Plus platform called Mission Control. This dashboard gives supervisors real-time visibility and actionable insights to drive performance, improve process flow, and optimize automation.

Matt Brown, VP of Telehealth at Advisory Services at CHG Healthcare, discusses the current state and future of telehealth, including the rapid adoption during the COVID-19 pandemic, the role of technology and AI in enhancing telehealth experiences, and how telehealth can help address physician and nurse burnout. Improved internet access, mobile device usage, and consumer preferences for convenience have driven the increasing telehealth usage for initial visits, follow-up appointments, and chronic care management.   Matt explains, "We are the nation's largest staffing agency. So, we're actually the founders of what's known as the locum tenens marketplace. CHG has been a pioneer in bringing physician services into remote and rural locations across the United States for the past four years. And over the last 10 years or so, we've continued to innovate on top of that physician-led experience and started to bring technology operations, as well as consulting services and telehealth, into the marketplace. So think of us as providing a broad array of staffing services, but also on top of that, technology and operations, and consulting that help the largest health systems in the country manage their physician workforce."   "It's been widely adopted since the pandemic. If you think about coming out of the pandemic, a lot of our health systems and hospitals were really forced to do a few things. One, they really had to upgrade a lot of their infrastructure and technology. So that meant that they were bringing broadband access into their hospitals. They started to think about how they could deliver care to their patients more remotely. And as they were doing a lot of these technology upgrades, they also started to address patients more like consumers. So I think that there was a big shift that started to take place in consumer services, starting to look like healthcare services."   "About that same time, you had a number of very large retail-focused, consumer-focused companies start to enter into the healthcare marketplace. So these are folks like Amazon, you have CVS and Walgreens, and now you've had a number of companies like Hims and Hers, and all of those are entering into the healthcare ecosystem through telehealth as a channel. So, as we've seen this increased infrastructure, this improvement in infrastructure, as well as consumerization of healthcare, continue to accelerate after the pandemic, and now we have more of this consumer-centric focus coming from a retail perspective."   #CHFGHealthcare #MedAI #DigitalHealth #PatientAccess #Telehealth #PhysicianBurnout #ClinicianBurnout CHGHealthcare.com Download the transcript here

Matt Brown, VP of Telehealth at Advisory Services at CHG Healthcare, discusses the current state and future of telehealth, including the rapid adoption during the COVID-19 pandemic, the role of technology and AI in enhancing telehealth experiences, and how telehealth can help address physician and nurse burnout. Improved internet access, mobile device usage, and consumer preferences for convenience have driven the increasing telehealth usage for initial visits, follow-up appointments, and chronic care management.   Matt explains, "We are the nation's largest staffing agency. So, we're actually the founders of what's known as the locum tenens marketplace. CHG has been a pioneer in bringing physician services into remote and rural locations across the United States for the past four years. And over the last 10 years or so, we've continued to innovate on top of that physician-led experience and started to bring technology operations, as well as consulting services and telehealth, into the marketplace. So think of us as providing a broad array of staffing services, but also on top of that, technology and operations, and consulting that help the largest health systems in the country manage their physician workforce."   "It's been widely adopted since the pandemic. If you think about coming out of the pandemic, a lot of our health systems and hospitals were really forced to do a few things. One, they really had to upgrade a lot of their infrastructure and technology. So that meant that they were bringing broadband access into their hospitals. They started to think about how they could deliver care to their patients more remotely. And as they were doing a lot of these technology upgrades, they also started to address patients more like consumers. So I think that there was a big shift that started to take place in consumer services, starting to look like healthcare services."   "About that same time, you had a number of very large retail-focused, consumer-focused companies start to enter into the healthcare marketplace. So these are folks like Amazon, you have CVS and Walgreens, and now you've had a number of companies like Hims and Hers, and all of those are entering into the healthcare ecosystem through telehealth as a channel. So, as we've seen this increased infrastructure, this improvement in infrastructure, as well as consumerization of healthcare, continue to accelerate after the pandemic, and now we have more of this consumer-centric focus coming from a retail perspective."   #CHFGHealthcare #MedAI #DigitalHealth #PatientAccess #Telehealth #PhysicianBurnout #ClinicianBurnout CHGHealthcare.com Listen to the podcast here

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers (where provider quality and convenience are comparable).” This strategy enables companies to save thousands of dollars per patient annually while enhancing the quality of care. As generative AI transforms industries, the question is no longer whether to adopt it, but how to do so ethically and effectively in healthcare.Can AI help people find the right doctor—not just any doctor—while saving employers money and simplifying decision-making?This episode of I Don't Care, hosted by Dr. Kevin Stevenson, features Dr. Daniel Stein, internal medicine physician and CEO of Embold Health. Together, they unpack how Embold's AI-powered platform is redefining care navigation through clinical logic, natural language processing, and massive datasets, guiding patients to high-performing providers matched to their needs and preferences.Key Highlights from the Conversation:AI That Guides, Not Replaces: Embold uses generative AI to replicate a physician's triage logic and connect patients with the most appropriate, clinically validated provider, without needing a medical degree to navigate the platform.Cost Savings Through Quality: Employers using Embold's navigation tools have seen care costs drop 3–5% annually by steering employees to top providers, without relying on pricing alone.Guardrails and Transparency: Backed by Microsoft's responsible AI standards, Embold's platform is bias-tested and built on a foundation of over 230 million medical records, ensuring recommendations prioritize outcomes and trust.Dr. Daniel Stein is a physician and healthcare executive with deep experience across clinical care, health policy, and corporate leadership. He is the founder and CEO of Embold Health, where he leads efforts to improve care quality through data-driven physician performance analytics. Previously, he served as Chief Medical Officer at Walmart Care Clinics and held policy roles with the U.S. Senate and CMS, bringing a unique blend of clinical insight and system-level strategy to healthcare reform.

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Dr. Julie Allickson, Chief Technology Officer for Mayo Clinic's Center for Regenerative Biotherapeutics. With over 30 years pioneering regenerative medicine - from early bone marrow transplant programs to today's cutting-edge cell and gene therapies - Julie shares her journey and insights on translating innovative therapies from discovery to clinical impact.Together, they explore how academic medical centers are evolving to bridge the gap between research and commercialization through integrated manufacturing capabilities, multi-site clinical trials, and strategic partnerships. Julie discusses Mayo Clinic's approach to managing 30+ clinical trials across three sites, the critical role of automation and AI in reducing costs and improving scalability, and why thinking about commercial viability early in development is essential widespread patient access.Learn more: https://www.linkedin.com/in/julie-g-allickson-phd-76129062/

Why do life-changing medical innovations often struggle to reach the patients who need them most? In this episode of Patient Advocacy Voices, Esther Krofah of the Milken Institute moderates a powerful conversation with senior Sanofi leaders across immunology, vaccines, diabetes, and policy on the systemic barriers that stand between scientific breakthroughs and ensuring access for patients in need. The conversation was recorded in February 2025 at the Sanofi Patient Advocacy Council.You'll hear candid insights on:The "last mile" problem in getting therapies to patientsReal-world examples of how insurance hurdles delay or deny carePolicy shifts that could better reward innovation while reducing patient burdenThe urgent need for representative clinical trial recruitmentHow collaboration across advocacy, industry, and government can drive changeThis episode offers both a frank view of patient access challenges and a clear call to action for working together, boldly and specifically, to make the system work better for patients.

Stay tuned to the end of the episode for a policy update on the bill containing Medicaid cuts that is making its way through Congress, and the recent MAHA Commission Report. If you were to ask any healthcare leader what the top challenges in our industry are, it's a fair bet that “improving patient access to care” would be on the list. There have been so many investments made in the industry to improve access—especially since the Covid-19 pandemic. With this level of investment, we should be moving the needle. But the data shows that access is not getting better, and in some cases, it's getting worse. This week, Advisory Board physician and medical group expert Mahaya Walker joins host Abby Burns to unpack why, and what medical groups can do about it. They break down Advisory Board research findings around how a narrow focus on improving appointment availability may actually be hurting efforts to improve access, and how medical groups can move the needle on access by putting clinicians closer to the center of their access strategies. Links: Provider availability: A new way to measure access for medical groups Top 3 opportunities to save provider time on administrative tasks Ambulatory access: How to make sustainable progress How to reduce in-basket overload by 34%, in 4 steps 4 ways to improve site-of-care transitions for sickle cell patients How VCU built an ‘inescapable' Adult Sickle Cell Medical Home to improve inpatient to outpatient transitions of care 4 keys to success in the New England Sickle Cell Institute's outpatient program for adult sickle cell patients A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

“There are so many more opportunities today for pharmacists that we haven't even dreamed of. In the future, pharmacists are going to provide more direct patient care, like pharmacogenomics, such as point of care testing for influenza and strep throat, and collaborative practice agreements that allow us, through a physician sign-off or medical practice sign-off, to manage and monitor medications." Steven Simenson, BPharm, FAPhA, FACA, DPNAP is the CEO and Managing Partner of Goodrich Pharmacy, Inc., with five community pharmacies in Minnesota. He is a graduate of the University of Minnesota College of Pharmacy along with his wife, Wendy, also a Pharmacist. Steve was the 2013-2014 President of the American Pharmacist's Association and is on the Board of Directors of Pharmacists Mutual Insurance Companies and the Community Pharmacy Foundation. He is actively advocating for the pursuit of Patient Access to and Coverage for Pharmacist Patient Care Services. Steven is at his best taking care of patients.

Dr Frances O'Hagan from BMA NI and politicians talk to Nolan

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Reducing patient wait times requires optimizing both patient navigation and health system resource utilization, a dual challenge tackled by platforms like DexCare.  In this episode, Jamie Gier, Chief Marketing Officer at DexCare, shares how their patient access platform, originally spun out of Providence Health, is working to ensure that "nobody waits for care." She explains how DexCare reduces appointment wait times by optimizing patient search and discovery while matching demand with the right clinician, location, or virtual care option, particularly for low-acuity needs. Jamie also discusses the importance of addressing generational expectations, the digital needs of caregivers, and the competitive landscape of B2B health tech marketing, which demands a precise ideal customer profile. Finally, she highlights the balance between AI-driven solutions and relationship marketing, emphasizing that trust remains key in partnering with health systems. Tune in and learn about innovative patient access solutions and insightful B2B healthcare marketing strategies! Resources:  Connect and follow Jamie Gier on LinkedIn. Learn more about DexCare on their LinkedIn and website. Discover more about CMO Huddles on their website and LinkedIn.

In this episode, Crystal Broj, Enterprise Chief Digital Transformation Officer at the Medical University of South Carolina (MUSC), shares how the organization is transforming healthcare through AI-powered voice bots, ambient listening, and digital front door innovations. She discusses the challenges and successes of implementing a new patient check-in system and deploying an automated AI agent in their patient access center. Crystal notes that one of the biggest lessons is the value of starting small—piloting technology, demonstrating ROI and KPIs, and scaling gradually. MUSC's AI voice bot – Emily – handles after-hours calls and appointment rescheduling, generating over $3 million in collections and reducing call handling time. Ambient tools like DAX have helped physicians cut “pajama time” by 37%, speed up chart closure, and improve clinical documentation. She also highlights how digital tools in the patient access center enhance scheduling and virtual care access, creating a seamless digital front door.  Crystal stresses the need for agile implementation, effective change management, and aligning technology with real workflows to drive lasting impact. Take a listen.

AI agents are transforming the front-end of the revenue cycle by capturing documents, verifying data, and launching workflows before staff even log in. In this episode, we explore how these digital teammates increase throughput, reduce rework, and empower your team to focus on high-value tasks.

How One Leader Came Out of Retirement to Transform Home Healthcare Jasper Freeman, Director of National Accounts at SC Pharmaceuticals, didn't just return to medical sales—he came back with a mission to change it. In this episode, Jasper shares how he helped launch Ferosix, a revolutionary heart failure treatment designed to keep patients out of the hospital and improve care at home. But that's just the beginning. We dive into: The untold story of Pharmacy Benefit Managers (PBMs) and their massive influence over drug pricing and access Why the insurance-sales-patient triangle is the key battleground in healthcare innovation What the U.S. can learn from other countries about lowering costs and improving care Bold reform ideas—from slashing med school tuition to rethinking drug distribution This is a rare, behind-the-scenes look at the business of healthcare, guided by someone who's lived it at the highest levels. If you're in medical sales—or trying to break in—this episode is a masterclass on what's next and how to lead the change. Connect with Jasper: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!

Seamless integration with EHRs is foundational to scaling patient access automation and optimizing revenue cycle performance. In this episode, Client Implementation Specialist Sahana Gangal explains how Infinx approaches standard and custom integrations, overcomes vendor limitations, and ensures successful data exchange across healthcare systems.

The creation of the not-for-profit CommonWell Health Alliance in 2013 was a turning point for data use and interoperability in the U.S. health care market. Many of the largest EHR vendors, clinicians, and others came together to cooperate on carrying out the mission of the HITECH act and the foundations for value-based care.This video interviews Paul L Wilder, Executive Director, and Liz Lewis, Director of Product, at CommonWell Health Alliance. They talk about the increase in the size of health care documentation, the Alliance's increasing integration of payers, the importance of patient access to records, and more.Learn more about CommonWell Health Alliance: https://www.commonwellalliance.org/Health IT Community: https://www.healthcareittoday.com/

In this episode of the Becker's Healthcare Podcast, Brook and Jocelyne from Verifiable dive into the critical connection between provider network growth, payer collaboration, and the modernization of credentialing systems. They explore how outdated legacy systems hinder patient access and provider onboarding, and share actionable strategies for healthcare leaders to improve compliance, reduce delays, and prepare for upcoming NCQA changes. With real-world examples — including Midi Health's rapid nationwide expansion — this discussion offers a forward-looking roadmap for building more efficient, scalable, and patient-centered networks.This episode is sponsored by Verifiable.

In this thought-provoking episode of This Week in Pharmacy, I am joined by three powerhouse leaders from health innovation: Dr. Alex Ding (Humana), Dr. Marc Watkins (Kroger Health), and Brian Urban (Best Buy Health). Together, they explore the next generation of patient access—where healthcare meets lifestyle, nutrition, and digital convenience. Special Guests:  Dr. Alexander Ding, MD, MBA – Medical Director, Humana Dr. Marc R. Watkins, M.D. – Chief Medical Officer, Kroger Health Brian Urban – Head of Innovation, Best Buy Health From food-as-medicine initiatives and retail-driven clinical models to smart tech integration in chronic care, this episode examines how cross-industry collaborations are shaping the future of health. It's not just about treating illness—it's about engineering longevity.

What does patient access really mean, and how can we make it better? Adam Mariano, General Manager of Healthcare at LexisNexis Risk Solutions, tackles this question head-on. In this interview, he discusses why patient access is more than just a DEI issue and shares what healthcare organizations can do to remove barriers to care. Plus, he gives a sneak peek into what LexisNexis Risk Solutions is working on to help hospitals and payers improve access with better data and real-time insights. Learn more about LexisNexis Risk Solutions at https://risk.lexisnexis.com/healthcare Find more healthcare marketing stories at https://swaay.health

In this episode of the NAHAM Connections Podcast, National Director of Experience at Ensemble Health Partners, member of the NAHAM Publications Committee and host Susan Milligan, CHAM, CRCR, is joined by Kobe Crossley, CHAM, CRCR, Patient Access director at Banner Health. Together, they explore the growing influence of ambulatory care and its impact on Patient Access professionals. Kobe, with her extensive experience in ambulatory care, shares valuable insights on the key factors driving the shift toward outpatient procedures, as well as the emerging challenges and best practices for Patient Access teams. She discusses how the rise in ambulatory care is prompting Patient Access professionals to adapt to evolving workflows, insurance requirements and access challenges. Kobe also highlights how automation and digital tools improve efficiency while enhancing the overall patient experience. Susan and Kobe dive into the strategies that Patient Access leaders can use to stay ahead, emphasizing the importance of continuous learning, industry certifications and sharing knowledge with colleagues. Tune in for Kobe's expert perspectives on navigating the evolving ambulatory care landscape and positioning Patient Access teams for future success. || LINKS *Episode* https://www.naham.org/page/ConnectionsConsiderationsforPriceTransparencyinAmbulatoryCare https://www.naham.org/page/ConnectionsPodcastEpisode23 https://www.naham.org/page/PatientAccessInTelehealth https://www.naham.org/page/HowBannerHealthBoostedPointofServiceCollectionsin2024 https://www.naham.org/page/AccessKeys?&hhsearchterms=%22access+and+keys%22 *Social Media* https://www.naham.org/page/NAHAMConnections | https://www.facebook.com/NAHAMDC/ | https://twitter.com/MyNAHAM | https://www.instagram.com/nahamdc/ | https://www.linkedin.com/company/national-association-of-healthcare-access-management-naham-/ *NAHAM Website* https://www.naham.org/ | https://www.naham.org/page/NAHAMConnections

Patient access errors like eligibility verification mistakes and missed prior authorizations can quietly drain millions in lost revenue. In this episode of RCMinutes, we explore how AI automation agents help eliminate these front-end issues, reduce denials, and safeguard profitability for healthcare organizations.

In this episode, we sit down with Franziska Jovin, Chief Experience Officer and Senior Vice President of Patient Access at Cooper University Healthcare. Here, she discusses advancements in patient experience and how her background in inpatient care has shaped her approach to ambulatory operations. Jovin also shares insights on creating seamless, patient-centered healthcare experiences.

In this episode, June Scarlett, Chief of Patient Access at White Plains Hospital, discusses the hospital's 2025 goals, including expanding specialty care, leveraging AI-driven technology, and addressing workforce challenges. She also shares insights on balancing high-tech solutions with a human touch and her leadership approach in navigating evolving healthcare demands.

In this episode, we sit down with Franziska Jovin, Chief Experience Officer and Senior Vice President of Patient Access at Cooper University Healthcare. Here, she discusses advancements in patient experience and how her background in inpatient care has shaped her approach to ambulatory operations. Jovin also shares insights on creating seamless, patient-centered healthcare experiences.

Discover how to optimize work queues in Patient Access Plus Workforce Management to streamline patient access workflows, enhance team productivity, and leverage AI-driven automation for case management.Brought to you by www.infinx.com

Wildfires have ravaged South California in recent months, forcing health system leaders to navigate patient access disruptions while ensuring continuity of care. Beyond the immediate crisis, these disasters create lasting "access debt"—a backlog of delayed appointments and unmet patient needs that can overwhelm health systems long after the flames have died down. How can access leaders prepare for and recover from such disruptions?This month, Founder and Executive Director Elizabeth Woodcock sits down with Aimee Corke, Director of Emergency Management and Business Continuity at Northwell Health; Connie Lee, MPH, FACHE, Senior Director of Patient Access at UCLA Health; and Leigh Bouskila Turk, MHA, Director of Practice Development and Support Services at Nicklaus Children's.The leaders share firsthand experiences managing patient access during wildfires, hurricanes, and other emergencies—discussing business continuity strategies, recovery planning, and how to maintain access in the face of disruption.

Dr. Phil and Dr. Andrew Hartz, Founder & President of the Open Therapy Institute (OTI) https://www.opentherapyinstitute.org/ delve into the complex intersections of therapy with cultural and political dynamics. They explore the current shift towards a more politicized mental health field, highlighting the challenges and implications of departing from traditional patient-centered care models. Discover how the Open Therapy Institute is at the forefront of reimagining therapy by emphasizing a patient-centered approach that respects and embraces diverse worldviews without bias. Dr. Hartz discusses the importance of openness, curiosity, and engaging with differing perspectives as vital components of the therapeutic process. Also, identify the negative impact of cancel culture on patient access to mental health services and the ethical imperatives that must guide therapy in these turbulent times. Now is the time to return to foundational, unbiased care in the mental health field. Thank you to our sponsors: Beam: Visit https://ShopBeam.com/DrPhil and use code DRPHIL for up to 40% off. Preserve Gold: Visit: https://preservegold.com/ Get a FREE precious metals guide that contains essential information on how to help protect your accounts. Text “DRPHIL” to 50505 to claim this exclusive offer from Preserve Gold today.

In this episode, Lisa Griffin, Lisa Griffin, MBA, CCCM - Chief Consumer Officer, Consumer Experience and Patient Access at University Hospitals, discusses the hospital's commitment to community care, groundbreaking advancements, and strategies for improving patient access and workforce engagement. Lisa shares her leadership insights and the organizational goals shaping 2025, including cultural transformation, digital innovation, and operational efficiency.

In this episode of Revenue Cycle Optimized, Jennifer Glockzin, Senior Manager of Patient Access, demystifies the complex world of medication authorizations. Learn about the two primary types of medication prior authorizations, the role of pharmacy benefit managers (PBMs), and how tools like CoverMyMeds streamline the process.

If you have zero clue what co-pay maximizers and/or co-pay accumulators are and the financial incentives involved for PBMs (pharmacy benefit managers) and plan sponsors here, after you're done listening to this episode, go back and listen to the show with Joey Dizenhouse (EP423). Also, the episode called “Game Theory Gone Wild” with Dea Belazi, PharmD, MPH (EP293). Both these shows could fill in some blanks. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Here's the micro mini of the co-pay maximizer/accumulator deal. These are vehicles that are designed by vendors who are also sometimes called maximizers or sometimes they're also PBMs. But these programs are designed to get as much money out of Pharma as possible in the form of co-pay support. So, here's how the maximizers are supposed to maximize plan sponsors getting pharma money. Say, for some drug, the pharma company has, I don't know, $12,000 max in co-pay support available to patients in total per year. Pharma does always cap the dollars that are available for patients. So, in this hypothetical, $12k a year is available. What a forthright or well-run maximizer will do is figure out, you know, if there's $12k max available, then they'll set a co-pay—so there's variable co-pays for patients—so they'll set a patient co-pay of, like, $1000 a month, which adds up to $12k over 12 months of the year. Get it? Every single month, the patient has a $0 co-pay, but the plan maximizes the dollars that the plan gets. Or, you know, maybe they'll charge $1,025 a month so the patient has some small “skin in the game,” and the plan sponsor just banked $12k. Sounds great, right? Well, sure, when it works as promised … and we'll get to this in a moment. Accumulators, on the other hand, have no such “Hey, let's make sure the patient actually gets their meds” guardrails. They hear that the Pharma is offering $12k, and the accumulator vendor and their plan sponsor clients also are like, “Cool, let's get that money as fast as possible.” So, they make the co-pay for that drug, I don't know, like hypothetically $3000. Great, now the patient runs out of that co-pay money in May. And don't forget and/or let me inform you, for both maximizers and accumulators, dollars paid by the Pharma generally don't count to the plan deductible for the patient. So now, the patient walks into the pharmacy, if in an accumulator or in a poorly run maximizer program, they walk into the pharmacy in May and are told that if they want their drug, they're gonna need to pay the $3000 co-pay that was set out of pocket every month until they reach their deductible. With some of these co-pay maximizer/accumulator plans, the plan sponsor may be a little bit out of the loop relative to what is actually going on here. The plan sponsor may think that members are doing fine—you know, they're getting their drug every month—so they may be surprised to learn about this running out of money in May issue. And what is true more often than it's not true, this $3000 or whatever—hundreds or thousands of dollars—payment due co-pay, the patient learns about it at the pharmacy counter or while trying to get chemo. It comes as a complete surprise, the fact that they owe three grand or whatever. What patient just shrugs and pays up in that moment because they happen to have their entire deductible or thousands of dollars lying around and at the ready? What a shock to find this out at the pharmacy counter or at the infusion clinic. Some of these maximizer programs are also starting to veer back into accumulator zones, like they're doing things such as saying that the member must pay their out-of-pocket max or their deductible or 30% of the cost of the drug, right, like some number before the plan will allow the patient to use the co-pay reimbursement program to begin with. So, there's other things that are emerging right now, which, again, cause the patient to have a very, very large out of pocket in order for them to get a drug which they have been prescribed and—ostensibly, at least—need. Allegedly, and sometimes for sure, dollars raked in from Pharma make it across the PBM/maximizer, vendor, middleman trench all the way over to the plan sponsor. For sure, especially for the administrative only maximizer vendors … yeah, you're gonna have the dollars actually making it to the plan sponsor. But sometimes the vendor running these programs is paid spread, right? So, the more expensive the drug and the richer the co-pay card program, the more the vendor will make because they take a percentage of savings. So, the more expensive, the more savings, therefore, the more the vendor is gonna make. In these cases where the vendor is paid a spread, can I take Perverse Incentives for $600, Alex? Right? But in sum, again, there's a lot to this conversation with Bill Sarraille, so please do listen to the whole thing. Bill offers five main pieces of advice, so I'm just gonna cover them right here up front—spoiler alert, I guess, but just to keep them all in one place. 1. Look into what is going on with a maximizer and/or accumulator program. First of all, is the plan sponsor paying spread? And also, how are these programs being marketed to members and how aggressively? Because there are a lot of plan sponsors having way more negative impact than they suspect they are. So, that's point of advice #1: Really look into actually what is happening on the grounds with some of these programs. 2. Eliminate surprise. Any plan sponsor listening, and Brian Reid also says this very crisply in an episode a month or so ago (EP456). If a plan sponsor wants to do stuff like this—like force a patient to pay hundreds or thousands of dollars out of pocket—if at any point during the year they are gonna wind up with thousands of dollars in co-pay or coinsurance to get their Crohn's disease med or cancer med or whatever, be really up front about this at least. It's really important if we really want to make sure that patients are taking maintenance meds and getting the medications that they're prepared for the reality that, at a certain point during the year, they are going to have a really big bill. 3. There is legal risk here. So also, Bill's advice is check into whether accumulators and/or maximizers are unlawful under the ACA (Affordable Care Act) and/or by deceptive practices rules when maximizers or accumulators are teed up as a benefit. And it, again (reference point of advice #2), it's not explained that dollars they get from Pharma will be taken by the plan and not applied to the patient deductible. I was just reading about the crazy aggressive marketing tactics that some of these vendors are using to get members to sign up and … yeah, definitely look into deceptive practice rules. 4. If it's utilization management that we're trying to achieve here, then your utilization manager should be utilization managing. These maximizers are not meant to impact utilization management. Patients really cannot differentiate, as per study after study, it's very difficult for patients to differentiate high-value from low-value care or meds. So, pretty much the impact of having a patient with thousands or hundreds of dollars of out-of-pocket spend to get a med isn't going to be to ensure that the right people are taking the right med. Point is, use the right tool for the right job. So, if we're trying to keep patients away from low-value meds, the tool for that is utilization management. Also be aware, if the PBM says it cannot do utilization management or you'll lose your rebates and/or is pushing into a maximizer accumulator program to do this instead, that's kind of a clue that they cannot do it because they are taking money from Pharma to not have any restrictions on a drug. Read the article in the New York Times (you're welcome) about how PBMs took secret payments for the free flow of opioids, and Chris Crawford also talks about this sort of same-ish thing in an upcoming show relative to GLP-1s. But if you're trying to do utilization management, then do utilization management. 5. Use our understanding of this whole goings-on as a rationale or a way to tamp down perverse incentives. We want to wind up with patients getting charged a percentage of net prices, not a percentage of some wildly inflated list price with this whole accumulator maximizer contributing to, you know, just more wildly inflated list prices so the co-pay programs can be bigger and someone can make even more money off of the percentage of savings. And plan sponsors addicted to rebates now have another bucket of cash. Like, this is just another example of how perverse incentives pervade the system. And we should certainly be aware of that. Bill Sarraille was a healthcare attorney for many years. He retired from his law firm on the first of last year, and now he's doing the things he wanted to do before but couldn't because his billable rate was too high. Bill is teaching at the University of Maryland Law School and doing some regulatory consulting, etc. He's working with a variety of patient groups. Also mentioned in this episode are University of Maryland Francis King Carey School of Law; Joey Dizenhouse; Dea Belazi, PharmD, MPH; Brian Reid; Chris Crawford; Marilyn Bartlett; Scott Haas; Paul Holmes; and Tom Nash. You can learn more at University of Maryland Francis King Carey School of Law and by following Bill on LinkedIn. You can also sign up for his Substack.   Bill Sarraille is a professor of practice at the University of Maryland Francis King Carey School of Law, a regulatory consultant, and a retired senior member of the Healthcare Practice group at Sidley Austin LLP. Bill is a nationally recognized expert in healthcare, life sciences, drugs, medical devices, and patient access to treatments. He is widely known for his expertise in a broad array of healthcare matters, including rare disease treatment access barriers, pharmaceutical pricing, Anti-Kickback Law compliance, the 340B program, and managed care and PBM issues. During his years practicing law, Bill was recognized repeatedly by The Best Lawyers in America in both healthcare law and administrative law. He was also consistently listed as a leader in the field of healthcare law in Chambers USA: America's Leading Lawyers for Business. Bill also serves as the general counsel of the charity the Pharmaceutical Coalition for Patient Access, as an advisor to multiple patient advocacy groups on patient access issues, a compliance advisor to a coinsurance patient assistance foundation, and as the director of a rare disease society and Kalderos, Inc., a health IT firm with a focus on effectuating pharmaceutical discounts and rebates.   09:31 What should plan sponsors be aware of right now? 14:01 What is the justification for maximizers, and why is this at odds with the purpose of insurance? 18:05 Where does the issue of “fairness” land within cost containment? 20:00 Brian Reid's LinkedIn post on insurance company access challenges. 21:30 What are the real legal issues presented by some of these co-pay maximizers and co-pay accumulator programs? 27:06 How are these programs creating perverse incentives? 29:28 EP450 with Marilyn Bartlett, CPA, CGMA, CMA, CFM. 32:16 “If you're covered by the ACA, I think this is unlawful.” 32:57 What advice does Bill have in regard to these programs? 33:49 What potential litigations does Bill see coming in the near future in regard to these co-pay maximizers and co-pay accumulator programs? 38:38 EP365 with Scott Haas. 38:45 EP397 with Paul Holmes.   You can learn more at University of Maryland Francis King Carey School of Law and by following Bill on LinkedIn. You can also sign up for his Substack.   @HCLAWComment discusses #costcontainment on our #healthcarepodcast. #healthcare #podcast #pharma #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Stacey Richter (INBW41), Andreas Mang (Encore! EP419), Dr Komal Bajaj, Cynthia Fisher, Stacey Richter (INBW40), Mark Cuban and Ferrin Williams (Encore! EP418), Rob Andrews (Encore! EP415), Brian Reid, Dr Beau Raymond, Brendan Keeler  

In this week's episode, hosts Reed Smith and Chris Boyer share their perceptions and insights on patient access - what it is, what internal and external factors are impacting access and then they dive into a recent study by Experian that implies that both patients and providers are feeling optimistic about access improvements in health systems. Lastly, they share some ways to implement a consumer-centric access strategy.  Mentions from the Show: Experian Health Report: The State of Patient Access – 2024 Consumer-Centric Patient Access: Insights from Top Providers Reed Smith on LinkedIn Chris Boyer on LinkedIn Chris Boyer website Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, National Director of Experience at Ensemble Health Partners, member of the NAHAM Publications Committee and host Susan Milligan, CHAM, CRCR, is joined by NAHAM President, Philip Quick, MPS, CHAM. They discuss the exciting milestones and ongoing progress of NAHAM as the organization celebrates its 50th anniversary. Philip shares his personal journey in Patient Access and reflects on the pivotal moments of NAHAM's evolution. From advocating for Patient Access leadership roles to navigating the challenges of the pandemic, he highlights the organization's adaptability in meeting the needs of healthcare professionals. Susan and Philip also take a deep dive into the future of NAHAM, focusing on the newly introduced tiered membership model, the re-accreditation of key certifications and the anticipated launch of the new Learning Management System (LMS) in 2025. Additionally, they discuss the upcoming release of Access Keys 5.0, which will include updates for both acute and ambulatory access. Tune in for insights on how NAHAM continues to shape the Patient Access field and how its members are contributing to the growth and leadership in healthcare. || LINKS *Episode* https://www.naham.org/page/ConnectionsPodcastEpisode24 https://www.naham.org/page/ConnectionsReunionWeekendACelebrationofNAHAMsLegacyandConnections https://www.naham.org/page/Connections50YearsofNAHAMCelebratingOurLegacyThrough5DecadesWith5Voices https://www.naham.org/page/ConnectionsNAHAM50thAnnualConferenceAdvancingPatientAccess https://www.naham.org/page/ConnectionsASpringboardtoSuccessPerspectivesfromFirst-timeNAHAMAnnualConferenceAttendees https://www.naham.org/page/AccessKeys *Social Media* https://www.naham.org/page/NAHAMConnections | https://www.facebook.com/NAHAMDC/ | https://twitter.com/MyNAHAM | https://www.instagram.com/nahamdc/ | https://www.linkedin.com/company/national-association-of-healthcare-access-management-naham-/ *NAHAM Website* https://www.naham.org/ | https://www.naham.org/page/NAHAMConnections

Partnering for Success in Patient Access Transformation Danelle Newman, Manager of Patient Access at OSS Health, shares her journey in overcoming challenges in patient access management. Learn how strategic partnerships, like the one with Infinx, helped streamline authorization workflows, manage staffing shortages, and ensure exceptional patient care. Danelle provides actionable insights and a firsthand perspective on the value of collaboration in healthcare operations. Brought to you by www.infinx.com. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Revenue Cycle Optimized, Danelle Newman, Manager of Patient Access at OSS Health, shares her journey in overcoming challenges in patient access management. Learn how strategic partnerships, like the one with Infinx, helped streamline authorization workflows, manage staffing shortages, and ensure exceptional patient care. Danelle provides actionable insights and a firsthand perspective on the value of collaboration in healthcare operations.

Send us a textEver tried to schedule a doctor's appointment, only to be stuck on hold for what feels like forever?You're not alone. A lot of Americans feel the same frustration.Could there be a better way to take control of scheduling?In this episode of HealthBiz Briefs, Relatient CEO Jeff Gartland explains why self-scheduling is still a novel concept in medicine and how its implementation can improve patient access while increasing appointment volumes for providers.This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.

Administrative staffing shortages are straining healthcare providers, especially in critical tasks like insurance verification and prior authorizations. In this episode, we explore how AI-driven solutions from Infinx are helping providers streamline workflows, maintain efficiency, and focus on delivering exceptional patient care despite limited resources.

In this episode, Patrick Kokoruda, MHA, CCSL, Vice President of Clinical Access Management, and George Ruiz, MD, a board-certified cardiologist and chair of Cardiology, both from Geisinger, discuss the transformative power of collaboration in improving patient access. They delve into the art and science of structuring clinicians' time, leveraging technology, and standardizing processes to connect patients with the right care at the right time. Hear their innovative approaches to optimizing capacity, addressing clinician shortages, and creating scalable, patient-centered solutions that redefine  access to care. 

On this episode of Managed Care Cast, we're talking with Josie Cooper, BA, executive director of the Alliance for Patient Access. Her study, "Utilization Management and Physician Burnout," involved a survey that assessed physician experiences with utilization management and burnout, investigating the potential link between the 2.

We love to hear from our listeners. Send us a message.Rita Johnson-Greene, COO at Alliance for Regenerative Medicine (ARM) joined Cell & Gene: The Podcast Host, Erin Harris, on site during 2024 Meeting on the Mesa to record their discussion. Johnson-Greene shared information about the Joint Clinical Assessment (JCA) in Europe and its potential impact on cell and gene therapies, how globalization impacts patient access, an update on ARM's Grow Internship Program, as well as a few key takeaways from the event that sector professionals can anticipate impacting the CGTs in the next 12 months and beyond.Subscribe to the podcast!Apple | Spotify | YouTube

In this episode, host Shikha Jain, MD, speaks with Amita Patnaik, MD, FRCPC, about providing patient access to breakthrough drug developments, bringing early phase cancer trials to physicians and more. •    Welcome to another exciting episode of Oncology Overdrive 0:14 •    About Patnaik 0:21 •    The interview 1:23 •    How did you decide to become an oncologist, and how did you end up co-founding the START Center for Cancer Research?  1:32 •    Can you tell me about START's overarching purpose and where you see its need being most fulfilled? […] What do you hope START will accomplish in the next five to ten years?  11:33 •    How successful has START been at including underrepresented patient populations in clinical data? 17:52 •    What are some challenges you've found as you have navigated through founding a company and executing its mission? 21:48 •    What is next for you?  25:21 •    If someone else wanted to create a company like START, what are some tips you would give them?  27:23 •    If someone could only listen to the last few minutes of this episode, what would you want them to take away? 32:03 •    How to contact Patnaik 34:44 •    Thanks for listening 35:27 Amita Patnaik, MD, FRCPC, is an internationally recognized medical oncologist and the co-founder of the START Center for Cancer Research. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Patnaik can be reached via email amita.patnaik@startresearch.com or via the START website.

In this episode, we dive into the fascinating intersection of artificial intelligence and pediatric neurology. Our guest shares how they became interested in AI's role in healthcare and discusses how AI is being utilized to enhance diagnostic accuracy, especially in neurodevelopmental pediatrics. We explore how these advancements are improving access to care in resource-limited settings and the impact of early diagnosis on long-term outcomes for conditions like autism. Join us as we uncover the latest technological innovations transforming pediatric healthcare, the potential of AI to personalize treatment plans for children, and the concerns surrounding the widespread use of AI in medicine. Dr. Sharief Taraman, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine. Dr. Taraman was the former Division Chief of Pediatric Neurology at Children's Health of Orange County and University of California-Irvine. He remains an active member of the medical staff and the Sharon Disney Lund Medical Intelligence, Information, Investigation, & Innovation Institute at CHOC. He is a Health Sciences Associate Clinical Professor at UC Irvine School of Medicine in the Department of Pediatrics and Affiliate Professor at Chapman University, Dale E. and Sarah Ann Fowler School of Engineering. Dr. Taraman is active in the community as the past president of the American Academy of Pediatrics (AAP) Orange County Chapter, board member of AAP-California, and committee member for the development of the AAP National CHILD health registry. He also serves on the Irvine Unified School District Medical Advisory Board, volunteers for the Capistrano Unified School District and with Girl Scouts of Orange County. Recognized globally as an innovator and specifically an advocate in the field of pediatrics, Dr. Taraman has been involved with the development of three FDA designated breakthrough devices, awardee of the prestigious National Capital Consortium for Pediatric Device Innovation grant, and is an advisor to Board of Directors for the International Society for Pediatric Innovation. He is the Chief Executive Officer at Cognoa and formerly served as the Chief Medical Officer leading the clinical trials that led to the FDA authorization of Cognoa's lead product, Canvas Dx, the first and only FDA authorized diagnostic device for autism for children 18-72 months old with concern for developmental delay. Dr. Taraman graduated Magna Cum Laude from the University of Michigan having majored in Biochemistry. He completed his medical education at Wayne State University School of Medicine and went on to complete residency and fellowship training in Pediatrics and Pediatric Neurology at the Detroit Medical Center and Children's Hospital of Michigan. He continued professional development through the University of California, Irvine - The Paul Merage School of Business with certifications in Leadership for Healthcare Transformation & Physician Leadership. https://cognoa.com/ _________________________________________________ Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter!www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

This episode of the Becker's Healthcare Podcast dives into the future of in-home care with Joseph Buchanan, SVP of Clinical Network at Matrix Medical Network, about how they prioritize high-quality care delivery in patients' homes. They discuss the importance of a clinician-led approach to in-home assessments and how it improves access, patient experience, and health equity for payers.This episode is sponsored by Matrix Medical Network.